000 01513 a2200421 4500
005 20250511183704.0
264 0 _c19921201
008 199212s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(92)90748-s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFink-Jensen, A
245 0 0 _aThe gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cSep 1992
300 _a197-201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aBrain
_xdrug effects
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aGlobus Pallidus
_xdrug effects
650 0 4 _aMale
650 0 4 _aNipecotic Acids
_xadministration & dosage
650 0 4 _aPentylenetetrazole
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSeizures
_xchemically induced
650 0 4 _aSubstantia Nigra
_xdrug effects
650 0 4 _aTiagabine
650 0 4 _agamma-Aminobutyric Acid
_xmetabolism
700 1 _aSuzdak, P D
700 1 _aSwedberg, M D
700 1 _aJudge, M E
700 1 _aHansen, L
700 1 _aNielsen, P G
773 0 _tEuropean journal of pharmacology
_gvol. 220
_gno. 2-3
_gp. 197-201
856 4 0 _uhttps://doi.org/10.1016/0014-2999(92)90748-s
_zAvailable from publisher's website
999 _c1432482
_d1432482